Research ArticleOriginal Article
Open Access

Complete blood cells count abnormalities in COVID-19 patients and their prognostic significance

Single center study in Makkah, Saudi Arabia

Amal E. Abd El-Lateef, Manar M. Ismail, Gamal Thabet and Nur-Anna Cabrido
Saudi Medical Journal June 2022, 43 (6) 572-578; DOI: https://doi.org/10.15537/smj.2022.43.6.20210893

References

  1. 1.↵
    1. Araya S,
    2. Mamo MA,
    3. Tsegay YG,
    4. Atlaw A,
    5. Aytenew A,
    6. Hordofa A, et al.
    Blood coagulation parameter abnormalities in hospitalized patients with confirmed COVID-19 in Ethiopia. PLoS One 2021; 16: e0252939.
    OpenUrl
  2. 2.↵
    1. Burki TK.
    Coronavirus in China. Lancet Respir Med 2020; 8: 238.
    OpenUrl
  3. 3.↵
    1. Yang L,
    2. Liu S,
    3. Liu J,
    4. Zhang Z,
    5. Wan X,
    6. Huang B, et al.
    COVID-19: immunopathogenesis and immunotherapeutics. Signal Transduct Target Ther 2020; 5: 128.
    OpenUrl
  4. 4.↵
    1. Mehta P,
    2. McAuley DF,
    3. Brown M,
    4. Sanchez E,
    5. Tattersall RS,
    6. Manson JJ.
    COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395: 1033–1034.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Tang N,
    2. Li D,
    3. Wang X,
    4. Sun Z.
    Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18: 844–847.
    OpenUrlCrossRefPubMed
  6. 6.
    1. Shang Y,
    2. Pan C,
    3. Yang X,
    4. Zhong M,
    5. Shang X,
    6. Wu Z, et al.
    Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China. Ann Intensive Care 2020; 10: 73.
    OpenUrlPubMed
  7. 7.↵
    1. Huang C,
    2. Wang Y,
    3. Li X,
    4. Ren L,
    5. Zhao J,
    6. Hu Y, et al.
    Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Ladikou EE,
    2. Sivaloganathan H,
    3. Milne KM,
    4. Arter WE,
    5. Ramasamy R,
    6. Saad R, et al.
    Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19? Clin Med (Lond) 2020; 20: e178–e182.
    OpenUrl
  9. 9.↵
    1. Lippi G,
    2. Plebani M,
    3. Henry BM.
    Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 2020; 506: 145–148.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Aktas G.
    A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection. Exp Biomed Res 2020; 3: 293–311.
    OpenUrl
  11. 11.↵
    1. Posul E,
    2. Yilmaz B,
    3. Aktas G,
    4. Kurt M.
    Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis? Wien Klin Wochenschr 2015; 127: 262–265.
    OpenUrl
  12. 12.↵
    1. Bilgin S,
    2. Aktas G,
    3. Zahid Kocak M,
    4. Atak BM,
    5. Kurtkulagi O,
    6. Duman TT, et al.
    Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men. Aging Male 2020; 23: 923–927.
    OpenUrl
  13. 13.↵
    1. Aktas G,
    2. Sit M,
    3. Dikbas O,
    4. Erkol H,
    5. Altinordu R,
    6. Erkus E, et al.
    Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto’s thyroiditis. Rev Assoc Med Bras (1992) 2017; 63: 1065–1068.
    OpenUrl
  14. 14.↵
    1. Tel BM,
    2. Kahveci G,
    3. Duman TT,
    4. Kurtkulagi Ö,
    5. Bilgin S,
    6. Senturk H, et al.
    A relapsing immune thrombocytopenia case in a patient following COVID-19 vaccination. J of Health and Allied Sci NU 2022; 12: 96–97.
    OpenUrl
  15. 15.↵
    1. Aktas G,
    2. Duman TT,
    3. Atak BM,
    4. Kurtkulagi O,
    5. Bilgin S,
    6. Basaran E, et al.
    Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters. Fam Med Prim Care Rev 2020; 22: 107–110.
    OpenUrl
  16. 16.↵
    1. Aktas G.
    Hematological predictors of novel Coronavirus infection. Rev Assoc Med Bras (1992) 2021; 67: 1–2.
    OpenUrl
  17. 17.↵
    1. Cai SH,
    2. Liao W,
    3. Chen SW,
    4. Liu LL,
    5. Liu SY,
    6. Zheng ZD.
    Association between obesity and clinical prognosis in patients infected with SARS-CoV-2. Infect Dis Poverty 2020; 9: 80.
    OpenUrl
  18. 18.↵
    1. Vahidy FS,
    2. Pan AP,
    3. Ahnstedt H,
    4. Munshi Y,
    5. Choi HA,
    6. Tiruneh Y, et al.
    Gender differences in susceptibility, severity, and outcomes of coronavirus disease 2019: cross-sectional analysis from a diverse US metropolitan area. PLoS One 2021; 16: e0245556.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Liang J,
    2. Nong S,
    3. Jiang L,
    4. Chi X,
    5. Bi D,
    6. Cao J, et al.
    Correlations of disease severity and age with hematology parameter variations in patients with COVID-19 pre- and post-treatment. J Clin Lab Anal 2021; 35: e23609.
    OpenUrl
  20. 20.↵
    1. Khalid A,
    2. Ali Jaffar M,
    3. Khan T,
    4. Abbas Lail R,
    5. Ali S,
    6. Aktas G, et al.
    Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis. Hematology 2021; 26: 529–542.
    OpenUrl
  21. 21.↵
    1. Taj S,
    2. Kashif A,
    3. Arzinda Fatima S,
    4. Imran S,
    5. Lone A,
    6. Ahmed Q.
    Role of hematological parameters in the stratification of COVID-19 disease severity. Ann Med Surg (Lond) 2021; 62: 68–72.
    OpenUrl
  22. 22.↵
    1. Yang AP,
    2. Liu JP,
    3. Tao WQ,
    4. Li HM.
    The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 2020; 84: 106504.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Liao D,
    2. Zhou F,
    3. Luo L,
    4. Xu M,
    5. Wang H,
    6. Xia J, et al.
    Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol 2020; 7: e671–e678.
    OpenUrlPubMed
  24. 24.↵
    Center for Disease Control and Prevention. Interim clinical guidance for management of patients with confirmed Coronavirus disease (COVID-19). [Updated 2021; 2021 Feb 2021]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
  25. 25.
    1. Guan WJ,
    2. Ni ZY,
    3. Hu Y,
    4. Liang WH,
    5. Ou CQ,
    6. He JX, et al.
    Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708–1720.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Fan BE,
    2. Chong VCL,
    3. Chan SSW,
    4. Lim GH,
    5. Lim KGE,
    6. Tan GB, et al.
    Hematologic parameters in patients with COVID-19 infection. Am J Hematol 2020; 95: E131–E134.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Wang D,
    2. Hu B,
    3. Hu C,
    4. Zhu F,
    5. Liu X,
    6. Zhang J, et al.
    Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061–1069.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Słomka A,
    2. Kowalewski M,
    3. Żekanowska E.
    Coronavirus disease 2019 (COVID-19): a short review on hematological manifestations. Pathogens 2020; 9: 493.
    OpenUrl
  29. 29.↵
    1. Araya S,
    2. Wordofa M,
    3. Mamo MA,
    4. Tsegay YG,
    5. Hordofa A,
    6. Negesso AE, et al.
    The magnitude of hematological abnormalities among COVID-19 patients in Addis Ababa, Ethiopia. J Multidiscip Healthc 2021; 14: 545–554.
    OpenUrl
  30. 30.↵
    1. Li Q,
    2. Cao Y,
    3. Chen L,
    4. Wu D,
    5. Yu J,
    6. Wang H, et al.
    Hematological features of persons with COVID-19. Leukemia 2020; 34: 2163–2172.
    OpenUrlCrossRef
  31. 31.↵
    1. Bellmann-Weiler R,
    2. Lanser L,
    3. Barket R,
    4. Rangger L,
    5. Schapfl A,
    6. Schaber M, et al.
    Prevalence and predictive value of anemia and dysregulated iron homeostasis in patients with COVID-19 infection. J Clin Med 2020; 9: 2429.
    OpenUrl
  32. 32.↵
    1. Gong J,
    2. Ou J,
    3. Qiu X,
    4. Jie Y,
    5. Chen Y,
    6. Yuan L, et al.
    A tool for early prediction of severe coronavirus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China. Clin Infect Dis 2020; 71: 833–840.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Tao Z,
    2. Xu J,
    3. Chen W,
    4. Yang Z,
    5. Xu X,
    6. Liu L, et al.
    Anemia is associated with severe illness in COVID-19: a retrospective cohort study. J Med Virol 2021; 93: 1478–1488.
    OpenUrlCrossRef
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords